[HTML][HTML] Pharmacological treatment of patients with mild to moderate COVID-19: a comprehensive review

RB Bestetti, R Furlan-Daniel, VMR Silva - International Journal of …, 2021 - mdpi.com
Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low,
mild to moderate COVID-19 may progress to severe or even critical stages in about one …

[HTML][HTML] From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?

M Guo, X Yu, YZ Zhu, Y Yu - Molecules, 2023 - mdpi.com
Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to
their outstanding physiological activities. Recently, applying imidazothiazole as the core …

The fragility of statistically significant results in randomized clinical trials for COVID-19

T Itaya, Y Isobe, S Suzuki, K Koike… - JAMA Network …, 2022 - jamanetwork.com
Importance Interpreting results from randomized clinical trials (RCTs) for COVID-19, which
have been published rapidly and in vast numbers, is challenging during a pandemic …

[HTML][HTML] Efficacy and outcome of remdesivir and tocilizumab combination against dexamethasone for the treatment of severe COVID-19: A randomized controlled trial

ATM Mohiuddin Chowdhury, A Kamal… - Frontiers in …, 2022 - frontiersin.org
Objective: In this study, we investigated the efficacy and safety of remdesivir and tocilizumab
combination therapy against dexamethasone for the management of severe COVID-19 …

[HTML][HTML] Simultaneous analysis of the of levamisole with triclabendazole in pharmaceuticals through developing TLC and HPLC–PDA chromatographic techniques …

KAM Attia, EA El-Desouky, AM Abdelfatah… - BMC chemistry, 2023 - Springer
Two simple and rapid chromatographic methods were developed and validated for the
analysis of levamisole and triclabendazole simultaneously in pure and pharmaceutical …

Current insights and molecular docking studies of the drugs under clinical trial as RdRp inhibitors in COVID-19 treatment

I Pauly, A Kumar Singh, A Kumar… - Current …, 2022 - ingentaconnect.com
Study Background & Objective: After the influenza pandemic (1918), COVID-19 was
declared a Vth pandemic by the WHO in 2020. SARS-CoV-2 is an RNA-enveloped single …

Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study

JT Campillo, C Eiden, M Boussinesq… - British Journal of …, 2022 - Wiley Online Library
Levamisole was initially prescribed for the treatment of intestinal worms. Because of
immunomodulatory properties, levamisole has been used in inflammatory pathologies and …

[HTML][HTML] Prospects of novel and repurposed immunomodulatory drugs against acute respiratory distress syndrome (ARDS) associated with covid-19 disease

SS Nayak, A Naidu, SL Sudhakaran, S Vino… - Journal of personalized …, 2023 - mdpi.com
Acute respiratory distress syndrome (ARDS) is intricately linked with SARS-CoV-2-
associated disease severity and mortality, especially in patients with co-morbidities. Lung …

[PDF][PDF] Development and validation of new analytical methods for the simultaneous estimation of levamisole and Albendazole in bulk and tablet dosage form by RP …

SK Ettaboina, K Nakkala - Journal of Pharmaceutical Analytics …, 2021 - researchgate.net
A reverse-phase high-performance liquid chromatographic (RP-HPLC) method was
developed to analyze levamisole and albendazole in tablet dosage forms. This method was …

[PDF][PDF] Clinicopathological evaluation of some immunostimulants' effects in Barki lambs

AA Darwish, MF Eldakroury - Iraqi Journal of Veterinary Sciences, 2023 - iasj.net
Levamisole, BCG, vitamin E & Selenium are traditional immunopotentiating agents. This
study aimed to monitor and compare between their effects on some clinicopathological and …